BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review

PL Santaguida, AC Don-Wauchope, M Oremus… - Heart failure …, 2014 - Springer
A systematic review was undertaken to examine the evidence for B-type natriuretic peptides
(BNP and NT-proBNP) as independent predictors of mortality, morbidity, or combined …

[HTML][HTML] Cardiac biomarkers: new tools for heart failure management

N Iqbal, B Wentworth, R Choudhary… - Cardiovascular …, 2012 - ncbi.nlm.nih.gov
The last decade has seen exciting advances in the field of biomarkers used in managing
patients with heart failure (HF). Biomarker research has broadened our knowledge base …

Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short-and long-term outcome in acute decompensated heart failure

M Noveanu, T Breidthardt, M Potocki, T Reichlin… - Critical Care, 2011 - Springer
Introduction Monitoring treatment efficacy and assessing outcome by serial measurements
of natriuretic peptides in acute decompensated heart failure (ADHF) patients may help to …

Brain-type natriuretic peptide and amino-terminal pro–brain-type natriuretic peptide discharge thresholds for acute decompensated heart failure: a systematic review

CN McQuade, M Mizus, JW Wald… - Annals of internal …, 2017 - acpjournals.org
Background: Acute decompensated heart failure (ADHF) requiring hospitalization is
associated with high postdischarge mortality and readmission rates. Purpose: To examine …

Breathing not properly 10 years later: what we have learned and what we still need to learn

AS Maisel, LB Daniels - Journal of the American College of Cardiology, 2012 - jacc.org
Since the initial studies showing the usefulness of B-type natriuretic peptide for aiding in
heart failure diagnosis, a vast number of other clinical applications for this neurohormone …

Long-term prognostic significance of plasma B-type natriuretic peptide level in patients with acute heart failure with reduced, mid-range, and preserved ejection …

Y Hamatani, T Nagai, Y Shiraishi, S Kohsaka… - The American Journal of …, 2018 - Elsevier
Plasma B-type natriuretic peptide (BNP) is an important prognostic marker in patients with
acute heart failure (AHF). However, it is unclear which BNP parameter, on admission, at …

Bioactive adrenomedullin, proenkephalin A and clinical outcomes in an acute heart failure setting

J Molvin, A Jujic, S Navarin, O Melander, G Zoccoli… - Open …, 2019 - openheart.bmj.com
Objectives In an acute heart failure (AHF) setting, proenkephalin A 119–159 (penKid) has
emerged as a promising prognostic marker for predicting worsening renal function (WRF) …

Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure

HJ Michtalik, HC Yeh, CY Campbell, N Haq… - The American journal of …, 2011 - Elsevier
The level of N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a predictor of adverse
events in patients with heart failure. We examined the relation between acute changes in NT …

NT-proBNP and its correlation with in-hospital mortality in the very elderly without an admission diagnosis of heart failure

R Sarzani, F Spannella, F Giulietti, M Fedecostante… - PloS one, 2016 - journals.plos.org
Background The diagnosis of heart failure (HF) is often difficult and underestimated in very
elderly comorbid patients, especially when an echocardiographic evaluation is not available …

Discharge BNP is a stronger predictor of 6-month mortality in acute heart failure compared with baseline BNP and admission-to-discharge percentage BNP reduction

HR Omar, M Guglin - International Journal of Cardiology, 2016 - Elsevier
Introduction Prior studies found a significant relationship between admission B-type
natriuretic peptide (BNP), discharge BNP and admission-to-discharge percentage BNP …